Skip to main content

Correction: myCAF-derived Exosomal PWAR6 accelerates CRC liver metastasis via altering glutamine availability and NK cell function in the tumor microenvironment

The Original Article was published on 18 December 2024

Correction: Journal of Hematology & Oncology (2024) 17:126

https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13045-024-01643-5

The authors wish to note a correction to an error in Figure 7F (LvPWAR6 group).

Due to the large number of serial sections of images, one section from the Control group was unintentionally mistakenly placed as the representative figure of the experimental group (LvPWAR6 group) in Fig. 7F. After carefully reviewing the original experimental records and raw data, the authors confirm that this was an unintentional error.

Fig. 1
figure 1

Experimental records of the NK1.1 immunofluorescence experiment

The authors conducted three repeat experiments of NK1.1 immunofluorescence for Fig. 7F and all of them reached the similar conclusion.

Fig. 2
figure 2

Three repetitions of the immunofluorescence experiment

The authors would like to emphasize that this error does not impact the scientific conclusions of the article, since the conclusion of Fig. 7F has been validated and supported by the results of the flow cytometry experiments in Fig. 7C-D. The NK1.1 immunofluorescence experiment of Fig.7 F was conducted merely as a further confirmation of the conclusion from Fig. 7C-D.

Fig. 3
figure 3

Corrected image for figure 7F in the original article

The authors also sincerely apologize for an incorrect image had been inadvertently included in Supplementary Figure 3D (DLD1/myCAFs group, transwell assay).

The authors provide the corrected image for the Supplementary Figure 3D (Figure 4 in this article) as well as the original experimental records and results from three repeated experiments for it (Figure 5 and Figure 6 respectively in this correction article).

Fig. 4
figure 4

Corrected supplementary figure 3De

The three repeated experiments of DLD1 transwell assays for Supplementary Figure 3D all reached the similar conclusion.

Fig. 5
figure 5

Experimental records of transwell assay

The authors wish to emphasise that this error was unintentional and does not impact the scientific conclusions of the article since the conclusion has also been validated in Supplementary Figure 3D/Spheroid formation assay and Supplementary Figure 3G (HCT116 transwell/Spheroid formation assay).

Fig. 6
figure 6

Three biological records of supplementary Figure 3D

In addition, the authors have also carefully reviewed the other raw data and did not find any other issues in our published article.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Xue Wang, Renjie Wang or Guoxiang Cai.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The online version of the original article can be found at https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13045-024-01643-5.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fang, H., Dai, W., Gu, R. et al. Correction: myCAF-derived Exosomal PWAR6 accelerates CRC liver metastasis via altering glutamine availability and NK cell function in the tumor microenvironment. J Hematol Oncol 18, 31 (2025). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13045-025-01685-3

Download citation

  • Published:

  • DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13045-025-01685-3